Qiuhua Sun

Qiuhua Sun


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in International Journal of Nursing Sciences
Verified
Journal Article
Open access
DSDan Song
Dan Song
QSQin Shen
Qin Shen
TXTu-Zhen Xu
Tu-Zhen Xu
QSQiuhua Sun
Qiuhua Sun
Background/purposeThe present meta-analysis was performed to evaluate the effectiveness of group reminiscence on depression in elderly patients.MethodsPublished and unpublished randomised controlled trials that assessed the effects of group reminiscence on depression in elderly patients were systematically reviewed using multiple electronic databases. Relative risks for dichotomous data and weighted mean differences for continuous data were calculated with 95% confidence intervals.ResultsTen trials were evaluated. Group reminiscence provided significantly greater relief of depressive symptoms than did the control intervention immediately after and 3 months after the intervention (p < 0.00001). However, this advantage disappeared 6 months after the intervention (p = 0.14). Group reminiscence significantly improved self-esteem and life satisfaction (p < 0.01).ConclusionGroup reminiscence was associated with short-term depression relief among elderly patients with depression and effectively improved self-esteem and life satisfaction. Higher-quality large-scale randomised controlled trials are needed to confirm these findings

16 August 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
RWRongyun Wang
Rongyun Wang
QSQiuhua Sun
Qiuhua Sun
FWFang Wang
Fang Wang
YLYuan Liu
Yuan Liu
XLXiang Li
Xiang Li
LLLu Li
Lu Li
Background: Ovarian cancer (OvC) is a malignant tumor which invades ovarian epithelium and interstitium. Reduction surgery combined with adjuvant chemotherapy is standard treatment for OvC patients, but the adverse effects due to chemotherapy still remains a major problem. While Chinese herbal medicine (CHM) therapy has a unique therapeutic effect to reduce side effects of chemotherapy by boosting immune system, the evidence of CHM in the treatment of OvC patients are limited. Objective: We conducted a systematic review to evaluate the efficacy and safety of CHM in the treatment of OvC after reduction surgery and adjuvant chemotherapy. Method: Chinese National Knowledge Infrastructure (CNKI) and PubMed up to Dec 31st 2018 were searched to identify relevant studies. Only randomized controlled trials (RCTs) were included, and there was no limitation on language of the publication. Data were extracted from all included studies and meta-analysis was performed with Review Manager 5.3. Study quality was assessed and pooled risk ratios (RR) or mean difference (MD) with 95% CIs were used to evaluate the efficacy and safety of CHM. Results: A total of 18 RCTs involving 975 participants were included. There was no placebo, no treatment and CHM alone. Compared with Western Medicine (WM) alone, Chinese herbal Medicine combined with WM (CHM-WM) significantly improved TCM syndromes and symptoms, KPS scores, CD4 counts, CA125 levels, and 3-years survival rate (P < 0.05). Incidences of gastrointestinal reactions, marrow depression, urinary system symptoms were significantly lower in CHM-WM group than in WM group (P < 0.01). There was no significant difference in CD3 counts, CD8 counts, quality of life, liver function, and peripheral neuropathy between the two groups (P > 0.05). Conclusion: The systematic review indicated that CHM combined with WM is effective and safe as a treatment for OvC patients after reduction surgery and adjuvant chemotherapy. However, more high-quality and large-scale RCTs are needed to confirm the efficacy and safety of CHM intervention.

1 December 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
DSDan Song
Dan Song
DYDoris Sau Fung Yu
Doris Sau Fung Yu
PLPolly Wc Li
Polly Wc Li
GHGuijuan He
Guijuan He
QSQiuhua Sun
Qiuhua Sun
Purpose: This study aimed to assess the health-related quality of life (HRQoL) and identify the important correlates of HRQoL in older Chinese adults with mild cognitive impairment (MCI). Patients and methods: A cross-sectional study design was adopted. A total of 204 older adults with MCI were enrolled in this study. HRQoL was evaluated by the Quality of Life–Alzheimer’s disease. Hierarchical regression analysis was conducted to investigate the sociodemographic, disease-related, psychological, and behavioral factors associated with the HRQoL of individuals with MCI. Results: Hierarchical regression analysis indicated that old age (Beta = −0.131, p =0.024), low income (Beta = 0.128, p = 0.032), depressive symptoms (Beta = −0.564, p < 0.001), and poor sleep quality (Beta = −0.169, p =0.004) were significantly associated with the HRQoL of individuals with MCI. Conclusion: Caring for older Chinese adults with MCI should focus on sociodemographically disadvantaged groups with advanced age and low income. Rehabilitation programs that effectively alleviate depressive symptoms and improve sleep quality should be applied to older adults with MCI to enhance their HRQoL.

1 September 2014 in International Journal of Nursing Sciences
Verified
Journal Article
Open access
DSDan Song
Dan Song
TXTu-Zhen Xu
Tu-Zhen Xu
QSQiuhua Sun
Qiuhua Sun
ObjectiveThe objective of this meta-analysis was to evaluate the effect of motivational interviewing (MI) on self-management in patients with type 2 diabetes.MethodsRandomised controlled trials that assessed the effects of MI on self-management and HbA1c levels in patients with type 2 diabetes were systematically reviewed using multiple electronic databases. Weighted mean differences with 95% confidence intervals were calculated for continuous data.ResultsTen trials were included in this meta-analysis. The self-management ability of patients with type 2 diabetes who underwent MI was significantly better than that of patients in the control group (WMD, 2.37; 95% CI, 1.77–2.98; p < 0.00001). Subgroup analysis showed that short-term MI (≤6 months) resulted in a significant decrease in the HbA1c level (p < 0.05) but that this advantage was not present for relatively long-term MI (>6 months) (p > 0.05).ConclusionsMI was associated with improved self-management abilities among patients with type 2 diabetes, and short-term MI (≤6 months) effectively decreased the HbA1c level. The effect of long-term MI (>6 months) on the HbA1c level remains uncertain. Large-scale, higher-quality randomised controlled trials are needed to confirm the present findings

1 January 2016 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
YZYunxian Zhou
Yunxian Zhou
CRCecelia Roscigno
Cecelia Roscigno
QSQiuhua Sun
Qiuhua Sun

30 June 2023 in Medicine
Verified
Journal Article
Open access
XLXiaoyan Li
Xiaoyan Li
LWLingyun Wu
Lingyun Wu
JYJie Ma Yun
Jie Ma Yun
QSQiuhua Sun
Qiuhua Sun
Type 2 diabetes mellitus (T2DM) is a chronic, lifelong disease that can negatively affect patients’ mental health and quality of life (QoL). A notable proportion of patients with T2DM worldwide have experienced stigma through instances of discrimination, unfair social treatment and lack of promotion opportunities. Stigma refers to the negative emotional experience of people with illness, often mixed with self-stigmatization. Stigma remains an obstacle to patients’ self-management, its association with patients with T2DM on medication adherence and QoL in China are unknown. Therefore, the objective of the study was to analyze the status of stigma in patients with T2DM and its association with medication adherence and QoL in China. A cross-sectional, observational study among 346 inpatients with T2DM in 2 tertiary-level hospitals in Chengdu, China, was conducted using a general data questionnaire, Chinese version type 2 diabetes stigma scale (DSAS-2), Morisky medication adherence scale (MMAS-8) and diabetic QoL specificity scale by convenient sampling method from January to August 2020. The total score and scores for the 3 dimensions of stigma, treated differently, blame and judgment, and self-stigma, were 54.30 ± 12.22, 16.57 ± 4.06, 20.92 ± 4.42, 16.82 ± 4.78, respectively. The scores for medication adherence and QoL were 5.43 ± 1.8 and 73.24 ± 9.38. Pearson correlation analysis showed that the total score of stigma and the scores of each dimension were negatively weak-correlated with the score of medication adherence (r = −0.158 to −0.121, P < .05), and positively moderate-correlated with the score of QoL (R = 0.073 to 0.614, P < .05). Stigma of patients with T2DM was negatively associated with medication adherence, and negatively associated with QoL, namely, the stronger the stigma, the worse the medication adherence and QoL. The results of the hierarchical regression analysis revealed that stigma independently explained 8.8% of the variation in medication adherence and 9.4% to 38.8% of the variation in QoL. The stigma of patients with T2DM was at a moderate degree and negatively correlated with medication adherence and QoL, it is necessary to pay more attention to relieve stigma and negative emotions timely, in order to improve patients’ mental health and QoL.